comparemela.com

Latest Breaking News On - Carrotize pr communications - Page 1 : comparemela.com

Allarity Therapeutics Stenoparib Shows Clear Clinical Benefit and Achieves Significant | Region

Boston (May 2, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced the early discontinuation of its Phase

Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement

Boston (April 29, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that on April 27,

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.